Archive for the ‘Medical Conditions’ Category

Recent Travel Newslinks

Thursday, April 28th, 2011 by

This week’s newslinks are meant to serve as a reminder that situations that are troublesome or unclear in the U.S. can be even more confusing abroad.

New Luggage Rule in EU Sows Confusion – Is it ok to travel with liquids on planes?

Many Restaurant Workers Don’t Understand Food Allergies – Be sure you bring translation cards or a medical term translation tool (like mPassport) to help clearly communicate your dietary restrictions with the wait staff.

A Business Traveler’s Guide to Naples – WSJ provides some useful and practical information on navigating the town and the business culture while on your business trip.

Share

Traveling Abroad with Prescriptions: It May Not Be As Easy As You Think

Wednesday, January 19th, 2011 by

Yesterday, The New York Times ran an article, Before Trip, Make Plans for a Dearth of Medicine, recounting the writer’s frustration with trying to get a prescription refilled in Puerto Rico. This article provides important reminders: things can go wrong, your trip can last longer than you expect, and things that can be handled with a simple phone call in the U.S. can become a major headache in another country.  

Many travelers are so used to taking their prescriptions that they only fret about forgetting to pack them when going on a trip. They don’t consider that they might lose or run out of their medicine (and if so, that the pharmacies may not accept called or faxed in orders from a U.S. doctor) or that their prescription could be for a drug that is illegal or unavailable in the country they are visiting. 

The U.S. Department of State offers advice for travelers going abroad with preexisting medical problems.  Travelers with prescriptions (including eyeglasses/contacts, allergy medicines, and birth control pills) should follow these guidelines to prepare before their trip:

  • Carry a letter from their doctor describing the medical condition and any prescription medication, including the generic names of prescribed drugs
  • Medications carried abroad should be left in their original containers and clearly labeled
  • Check with the foreign embassy of the country to make sure any required medications are not considered illegal in that country

Frank Gillingham, MD, a frequent contributor to HTB, provides some additional advice for those traveling with prescriptions in his Health and Safety Abroad series.

Do you need assistance finding out what your prescription is called or how it is prepared in another country?  HTH Worldwide  built, maintains and annually updates an international database of over 6,200 brand names for nearly 400 compounds in 28 of the most frequently visited countries around the world. This information, along with information on finding pharmacies and profiled doctors, is available to anyone covered by an HTH Worldwide health plan or through an mPassport subscription or downloadable iPhone apps. 

Photo by Smabs Sputzer.

Share

Traveling with A Medical Condition? Help the TSA Be Discreet

Tuesday, December 21st, 2010 by

The Transportation Safety Administration (TSA) has taken a step to improve the screening experience for travelers with medical conditions.  Following complaints from travelers who encountered embarassing or uncomfortable situations during security screenings, the TSA has issued health condition notification cards that travelers can fill out and discreetly hand to a TSA officer before going through the screening device.  The card, which does not exempt the traveler from screening,  states “I have the following health condition, disability, or medical device that may affect my screening:” followed by a blank area where travelers can fill in the name of their condition or choose to leave it blank. 

The back of the card reads “TSA respects the privacy concerns of all members of the traveling public.  This card allows you to describe your health condition, disability or medical device to the TSA officer in a discreet manner.  Alternate procedures which provide an equivalent level of security screening are available and can be done in private.”  The cards were distributed in October on a very limited basis but are now widely available. Visit the TSA website under “Travelers with Disabilities & Medical Conditions.” 

Kate Hanni of FlyersRights.org reports that the airline consumer organization receives complaints daily from people with disabilities who feel “completely disregarded and/or violated during their security check.”  These cards are a step in the right direction in making the security process as easy and private as possible, and the TSA is looking to make even more improvements in the future.

Share

Mental Illness: A Globally Underserved Condition

Thursday, October 7th, 2010 by

This Sunday, October 10, 2010, more than one hundred countries will recognize World Mental Health Day.  This annual observance, sponsored by World Federation for Mental Health (WFMH), was created 18 years ago in an effort to raise awareness of the seriousness of mental health at national, regional and local levels around the world.  The focus of this year’s events and programs is Mental Health and Chronic Illness: The Need for Continued and Integrated Care.  Though the focus of the day changes with the year, the goal of changing the perception, acceptance and attention given to mental illness stays the same.

Today, in support of this event and in recognition of the lack of qualified mental health specialists around the globe, the World Health Organization (WHO) published the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings.  According to the WHO website “The mental health Gap Action Programme (mhGAP) aims at scaling up services for mental, neurological and substance use disorders for countries especially with low- and middle-income. The program asserts that with proper care, psychosocial assistance and medication, tens of millions could be treated for depression, schizophrenia, and epilepsy, prevented from suicide and begin to lead normal lives– even where resources are scarce.”

This guide provides guidelines and clinical practices for primary care doctors to follow when treating a patient with a potential mental health issue.  This is invaluable in poor countries where any medical care can be hard to come by, and in more developed countries where it’s hard to find a mental health professional.  As we’ve stated in the past regarding mental health conditions around the globe, finding the right practitioner can be a challenge; in many cultures, physicians are not accustomed to prescribing medications for mental health conditions. Even in a western European country such as Germany, a wide and thorough search may be necessary to find a doctor that will provide care consistent with a treatment plan prescribed in the U.S.

These new guidelines will increase the likelihood that travelers will find competent providers of mental health services when seeking care far away from home.

Photo by Scootzsx.

Share

Public Health Workers Are in Short Supply; Epidemics Are the Winners

Wednesday, September 29th, 2010 by

With epidemics and outbreaks threatening many developing countries, there is a need for more epidemiologists and public health workers to collect data and respond to the situation.  International law now requires countries to report certain outbreaks or public-health events and to improve their disease surveillance and response capabilities, but a shortage of trained epidemiologists limits their ability to comply.  The Centers for Disease Control and Prevention (CDC) are helping to fund 35 programs mainly in developing countries to train health workers in epidemiology to better prepare them to identify epidemics.  Eleven more programs are in the works. According to the Wall Street Journal, the initiative is modeled after the CDC’s Epidemic Intelligence Service program, which helped to detect HIV/AIDS, eradicate smallpox, and discover a deadly strain of E. coli. 

By battling outbreaks such as the current cholera epidemic in Nigeria, the expansion of these programs can save many lives. Trained officers can track down cases, help treat patients and educate others.  CDC director Thomas Frieden said in an interview that if epidemiologists had been able to detect H1N1 in Mexico two months earlier, a vaccine would have been ready before the biggest peak hit the U.S. last year, and could have saved thousands of lives.  He believes that to be able to sufficiently measure disease threats, there needs to be at least one epidemiologist per 200,000 people. Using this rule of thumb, worldwide demand for epidemiologists would be 34,500 based on the 6.9 billion humans that inhabit the planet today. By some estimates there are no more than 5,000 worldwide today. Over the past 30 years, for example, only 2,200 people have graduated from CDC epidemiology programs. 

Despite this shortage of expertise, epidemiologists soldier on. Some of the outbreaks or public health problems currently being tracked by CDC-funded programs include:

  • Nigeria: Cholera epidemic that has led to more than 1,000 deaths
  • Ethiopia: Acute-diarrhea that sickened 10,000 in Addis Ababa
  • Kyrgyzstan: HIV among children in Bishkek
  • Ghana: Rabies
  • Egypt: H5N1 and H1N1 flu
  • Pakistan: Viral hepatitis
  • Thailand: Pneumonia in mushroom-farm workers caused by fungi
  • China: Melamine-contaminated infant formula

Source: Centers for Disease Control and Prevention

The CDC is expanding its training programs to include Vietnam, China, Kazakhstan, Uzbekistan, Ethiopia, Iraq and Afghanistan.  The CDC is also working on creating shorter courses to train local officials in basic data collection.  The competent collection of timely data leads to improved disease surveillance and response strategies from which the whole world benefits. 

Photo by Eneas.

Share

Heads Up for Diabetics: Avandia Unavailable in Europe and Restricted in the U.S.

Monday, September 27th, 2010 by

Under the terms of a landmark joint action announced last week by both the U.S. Food and Drug Administration (FDA) and the European Union’s European Medicine Agency (EMA), the availability of the diabetes drug Avandia will be limited or non-existent going forward.  Citing studies linking Avandia to increased risk for heart attacks and strokes, EMA authorities said sales will be prohibited, while the FDA will permit patients in the United States access under limited circumstances.

Avandia is used to treat Type 2 diabetes by increasing the body’s sensitivity to insulin. It continues to be widely available outside the U.S. and E.U.

One study conducted between 1999 and 2009 linked Avandia to 47,000 “unnecessary” cases of stroke, heart attack and heart disease.  The FDA’s authority to restrict the use of Avandia comes as a result of a law passed in 2007 that gives the agency new powers over drug makers and drug distributors. 

Although it is not clear why EMA officials in Europe banned the drug, there is speculation that authorities believe that a similar drug, Actos — shown in preliminary studies to demonstrate fewer heart attacks and less heart failure — is a suitable alternative.  The FDA appears less quick to judge.  Janet Woodcock, the director of the FDA’s Center for Drug Evaluation and Research and the author of the FDA statement, said “It is difficult to draw definite conclusions from the studies (done on Avandia and Actos), both because of the small size of the observed effects, and because it is not clear whether the findings, if valid, represent beneficial effects of Actos or toxicities of Avandia.”

In the meantime, diabetics who are currently taking Avandia and planning on traveling outside of the United States should ask their physicians about switching to Actos.  If that is not possible, visitors to Europe should make sure they have enough Avandia on hand to last the trip, as obtaining a prescription in Europe is no longer possible.

Share

Mono and the Study Abroad Student

Wednesday, July 21st, 2010 by

Mononucleosis – better known as “mono” or “kissing disease” is a common viral illness that afflicts thousands of young adults each year.  Although usually a benign condition, with symptoms of fever, headache, sore throat, fatigue and swollen lymph nodes – particularly in the neck – mononucleosis can occasionally lead to much more serious problems, and rarely even death, particularly in those with compromised immune systems such as people with HIV/AIDS or those taking drugs to suppress immunity after an organ transplant.

Students abroad seem to be particularly susceptible to contracting mononucleosis.  Over the past two months, HTH Worldwide has had two study abroad participants experience severe symptoms of mono.  One student developed significant abdominal tenderness with an enlarged spleen and hepatitis (liver inflammation), along with anemia (a low red blood cell count), and difficulty swallowing.  Her condition prompted transfer from a rural area with marginal medical facilities to an urban hospital, where she did not start improving until given very high doses of steroids.

The second patient developed dehydration from an inability to swallow, along with “ataxia” (loss of coordination) due to inflammation of the cerebellum (the part of the brain responsible for balance).  Indeed, patients with mononucleosis have been diagnosed with a number of other neurological complications, including Guillain-Barre syndrome (loss of motor strength similar to polio), meningitis, encephalitis, and seizures. 

Other rare conditions seen with mononucleosis include pericarditis (an inflammation of the lining of the heart), thrombocytopenia (a drop in platelets – the small cells responsible for blood clotting), and airway obstruction due to extraordinary tonsil enlargement.  Although some enlargement of the spleen is quite common in mononucleosis – almost fifty percent of all patients who are diagnosed with mono have some splenomegaly – life threatening splenic rupture may also occur either spontaneously or as a result of minor trauma, in a small number of cases.

Mononucleosis is extremely contagious, and seems to have a predilection for groups in close confinement.  In addition to kissing, the virus spreads easily from shared drinking glasses and utensils.  Rarely, the virus can be contracted from a blood transfusion.  Mononucleosis can remain contagious for weeks after the onset of symptoms, or even after most of the symptoms have resolved. 

Although there is no cure for mononucleosis, symptoms seem to improve with steroids.  Other measures that help alleviate symptoms include salt water gargles and anti-inflammatory medications such as acetaminophen (Tylenol) or ibuprofen (Advil).  Aspirin should be avoided, as its use has been linked to the development of Reyes syndrome – a liver disorder- particularly in those under 21.  Those infected should avoid heavy lifting or contact sports to reduce the risk of injuring the spleen.

The test for mononucleosis is not universally available, and the diagnosis is often missed outside of the United States, so maintain a high index of suspicion if you are a young student heading abroad for studies or leisure.

Photo by: hipposrunsuperfast.com

Share

Mosquitoes – A story of bad news, good news, beer and Malaria

Thursday, March 25th, 2010 by

Two stories concerning mosquitoes caught my attention recently.  In the age-old “bad news, good news” tradition, it goes like this:

“The bad news is that if you drink beer, mosquitoes are more attracted to you and may bite you and give you malaria.  The good news is that scientists have developed a mosquito that could, in theory, vaccinate you against malaria with each bite.”

The first study, Beer Consumption Increases Human Attractiveness to Malaria Mosquitoes, was conducted in Burkina Faso by a team of researchers led by Thierry Lefèvre from Emory University and published by PLoS ONE, an interactive open-access journal.  It concluded that “beer consumption consistently increased volunteers’ attractiveness to mosquitoes.”  The researchers believe that the alcohol in the local beer causes the increased attractiveness; however, further studies are necessary to eliminate other possibilities.  I saw that the local beer is fairly low in alcohol content and wondered what the curve would look like as the strength varied.  Is it a linear relationship, or would it yield an upside-down “U” shape?  If the latter, one could stick to more toxic drinks (although this flies in the face of the researchers who also noted that alcohol consumption has other negative health effects and can lower one’s ability to defend against parasites and other threats to the immune system).  I was lucky enough to learn about the African drink, dawa, from my wife (it was a huge hit on our wedding night).  Dawa means “medicine” or “magical potion” in Swahili and is a much stronger drink than the local beer in Burkina Faso, so perhaps they already know about the shape of the curve.

The second study, Flying vaccinator; a transgenic mosquito delivers a Leishmania vaccine via blood feeding, was published in the April 2010 issue of Insect Molecular Biology and conducted by Associate Professor Shigeto Yoshida and his research team from Jichi Medical University. Unfortunately, there are ethical issues with using wild mosquitoes (are there domesticated ones?) to transmit a vaccine.  How would the pharmas get paid for it, for example?  Oh, yeah, that is not an ethical issue so much as an economical one.  In all seriousness, it does sound like this idea may be years away if it ever gets off the ground (no pun intended).  The mere fact that they did successfully use the mosquito’s saliva to deliver the payload, however, does hold promise for other therapies in the future.

Malaria is a very serious problem worldwide, affecting hundreds of millions of people each year and killing millions, mostly sub-Saharan children.  If you took the time to read this, please think about helping to stop this disease and perhaps contributing to a worthy organization.  It is money well spent. Also, if you are traveling to areas where malaria is a risk, learn about which preventive medicine is right for you and make sure that you take it.

Photo info: http://www.flickr.com/photos/trebol_a/ / CC BY-NC 2.0
Share

Lactose Intolerant? — No cure for intolerance in France

Friday, March 19th, 2010 by

HTH Worldwide’s COO is in France today and just sent me an urgent email from his BlackBerry.  His daughter needs Lactaid®, but they can’t find it anywhere.  It would seem that a country that is the world’s largest exporter, the third largest producer and, most importantly, the second largest consumer of cheese would have discovered the benefits of Lactaid®, a dietary supplement that contains a natural lactase enzyme that helps you break down lactose. 

From my research, Lactaid® is only available in the U.S. and Canada.  There is a great forum discussion that took place in 2005 on Wordreference.com on the subject.  It talks about the history of Europe and dairy farming, lactose facts (there is more in milk and ice cream, less in cheese, especially hard cheeses), lactose intolerance levels in different geographic regions and even the availability of public restrooms in Paris.  For a much more scientific background, check out the Wikipedia lactose intolerance page.

I am now more aware than ever of lactose intolerance and even learned that February is Lactose Intolerance Awareness Month.  I will try not to miss the exciting events next year (things like “Be kind to your bloated, uncomfortable, and sometimes odoriferous workmate” or “Promote a no-cone zone in your lunchroom”). 

If you have no tolerance for lactose, don’t leave the U.S. and Canada without your own supply of Lactaid!

Photo info: http://www.flickr.com/photos/annamatic3000/ / CC BY-NC-ND 2.0
Share

Means to End Chikungunya Menace? Report Raises Hope

Friday, February 19th, 2010 by

New Scientist magazine is reporting a scientific advance that may hold the key to defeating  a mosquito-borne virus that turned dangerous and deadly and has been spreading across the world for the past five years. Carried by the tiger mosquito and driven by the forces of global commerce, chikungunya  virus causes fever, headache, nausea as well as excruciating pain in smaller joints, earning it the nickname “knuckle fever.”  This virulent form first appeared in the islands of the Indian Ocean but has since invaded every continent by way of airports and sea ports.   The CDC highlights some specific reports of recent activity in Indonesia, Thailand and Malaysia on their website, where they also offer advice to clinicians and travelers. 

Now the U.S.  National Institutes of Health (NIH) are reporting a breakthrough in the search for a vaccine by using genetic engineering to create virus-like particles which perfectly mimic the virus without being infectious. Tests with Rhesus monkeys have shown the vaccine to be completely effective against chikungunya. Testing in humans is likely to begin in one to three years.

The NIH’s work with chikungunya  may have ushered in a new era of vaccine production that could prove to be safer and more effective than the many live virus vaccines that are in use today.  It may only be a matter of time before vaccines created from pieces of viruses will replace those derived from whole, live viruses. Diseases such as Kala Azar, sleeping sickness and Dengue fever that afflict travelers to tropical regions do not currently have effective vaccines.  In principle, the creation of vaccines from virus like particles could someday eliminate that problem.

Photo info: http://www.flickr.com/photos/deadmike/ / CC BY-NC-SA 2.0

Share